Angiogenesis inhibition and tumor-immune interactions with chemotherapy by a control set-valued method
From MaRDI portal
Publication:541886
DOI10.1016/j.mbs.2011.02.010zbMath1214.92042WikidataQ51595754 ScholiaQ51595754MaRDI QIDQ541886
Publication date: 8 June 2011
Published in: Mathematical Biosciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.mbs.2011.02.010
93B52: Feedback control
93C95: Application models in control theory
92C50: Medical applications (general)
Related Items
Constrained bilinear control problem: Application to a cancer chemotherapy model, Optimal bounded controls problem for bilinear systems, Periodic solutions of angiogenesis models with time lags, On probabilistic certification of combined cancer therapies using strongly uncertain models, On dynamic tumor eradication conditions under combined chemical/anti-angiogenic therapies, A novel control set-valued approach with application to epidemic models, Qualitative analysis of tumor growth model under antiangiogenic therapy - choosing the effective operating point and design parameters for controller design
Cites Work
- Unnamed Item
- Optimal scheduling of radiotherapy and angiogenic inhibitors
- Immunotherapy: an optimal control theory approach
- Scheduling of angiogenic inhibitors for Gompertzian and logistic tumor growth models
- Modeling immunotherapy of the tumor -- immune interaction
- Continuous and discrete mathematical models of tumor-induced angiogenesis
- A hierarchy of cancer models and their mathematical challenges
- Mixed immunotherapy and chemotherapy of tumors: feedback design and model updating schemes
- Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis
- Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)
- A set-valued approach to control immunotherapy
- Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls
- Optimal control of treatment in a mathematical model of chronic myelogenous leukemia
- AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem
- ON THE FOUNDATIONS OF CANCER MODELLING: SELECTED TOPICS, SPECULATIONS, AND PERSPECTIVES
- A Unified Set-Valued Approach to Control Immunotherapy
- A family of models of angiogenesis and anti-angiogenesis anti-cancer therapy
- Mathematical modelling of the spatio-temporal response of cytotoxic T-lymphocytes to a solid tumour
- Feedback Spreading Control under Speed Constraints
- Cancer Modelling and Simulation
- Feedback Spreading Control Applied to Immunotherapy
- Target control by using feedback spreading control with application to immunotherapy
- Set-valued analysis
- Viability theory
- Simple ODE models of tumor growth and anti-angiogenic or radiation treatment